>> NEWS GOODIES <<

[Penny Roger$]

Proteo, Inc. / Proteo Biotech AG: Final Analysis of the Phase II Clinical Study on Elafin in Coronary Artery Bypass Surgery Completed
| 5:30 AM | |

IRVINE, Calif. & KIEL, Germany--(BUSINESS WIRE)--Proteo, Inc. (OTCQB: PTEO) and its wholly-owned subsidiary Proteo Biotech AG today announced that the NHS Lothian’s Edinburgh Heart Centre has completed final analysis of data from the investigator initiated Phase II clinical trial (EMPIRE study) with Proteo’s drug candidate Elafin for prevention of myocardial injury after coronary artery bypass surgery (CABG). The EMPIRE study was designed as a randomized, double-blinded and placebo-controlled s


Sticky | Label | Archive | Share | Menu | Related | Full Content |
http://feeds.businesswire.com/click.phdo?i=12c69d2f627b8d1db124d1a90f449735

~ Market News! ~

This news update brought to you by StockGoodies SizzlingStockPicks PennyStockTweets WallStreetSurfers and PennyStockMobsters.
Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html
http://www.stockgoodies.com/chart-school.html

~ http://www.fallenheroesfund.org/ ~
St. Jude 2014 Drive has started >> http://tinyurl.com/St-Jude-2014